Analysis of recurrent urinary tract infection (UTI) in University Hospital – approach of antibiotic resistance in clinical isolates
Keywords:Urinary tract infection; Antibiotic resistance; Multiresistant bacteria; UTI.
The fifty-two bacteria were isolated from urinary tract infections in University Hospital in Sumaré, São Paulo State, Brazil. These isolates were analyzed about their antibiotic resistance and their bacterial characteristics. Around percentage from these isolates were identified as belonging to Escherichia coli strains, followed by Klebsiella pneumoniae and Pseudomonas aeruginosa. The multiresistance profile (resistance profile major than four 4 antibiotic classes) were viewed in thirteen (13) strains of Escherichia coli, sixteen (16) strains in Klebsiella pneumoniae (being two (2) carbapenem resistant suggesting an existence of KPC strain). The results had demonstrated an indiscriminate antibiotic use concentrated in the increase of quinolones resistance (principally in ciprofloxacin use), and also the rise of KPC super bacteria.
Aldred KJ, Kerns RJ, Osheroff N. Mechanism of Quinolone Action and Resistance. Biochemistry. 2014 Mar 18;53(10):1565-74. PubMed PMID: WOS:000333235600004. English.
Alves, Danilo Antonini; Machado, D.; Melo, A.; Pereira, RFC; Severino, P.; Hollanda, LM; Araújo, DR; Lancellotti, M. Preparation of Thermosensitive Gel for Controlled Release of Levofloxacin and Their Application in the Treatment of Multidrug-Resistant Bacteria. BioMed Research International, v. 2016, p. 1-10, 2016
Anes J, McCusker MP, Fanning S, Martins M. The ins and outs of RND efflux pumps in Escherichia coli. Frontiers in microbiology. 2015 Jun 10;6. PubMed PMID: WOS:000356351200001. English.
Andriole VT. The quinolones: past, present, and future. Clinical infectious disease: an official publication of the Infectious Diseases Society of America. 2005 Jul 15;41 Suppl 2: S113-9. PubMed PMID: 15942877.
Baym, M., Stone, LK. and Kishony, R., “Multidrug evolutionary strategies to reverse antibiotic resistance,” Science, vol. 351, no. 6268, 2016.
Cavalieri, S. J. Manual of Antimicrobial Susceptibility Testintg, National Committee for Clinical Laboratory (NCCL), 2005.
Emmerson AM, Jones AM. The quinolones: decades of development and use. The Journal of antimicrobial chemotherapy. 2003 May;51 Suppl 1:13-20. PubMed PMID: 12702699.
Khameneh B, Diab R, Ghazvini K, Fazly Bazzaz BS. Breakthroughs in bacterial resistance mechanisms and the potential ways to combat them. Microbial pathogenesis. 2016 Feb 18. PubMed PMID: 26911646.
Mitscher LA. Bacterial topoisomerase inhibitors: quinolone and pyridone antibacterial agents. Chem Rev. 2005 Feb;105(2):559-92. PubMed PMID: 15700957.
NCCLS, M11-A6 Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria; Approved Standard, NCCLS, Philadelphia, Pa, USA, 6th edition, 2004.
Nebert DW, Zhang G, Vesell ES. From human genetics and genomics to pharmacogenetics and pharmacogenomics: past lessons, future directions. Drug metabolism reviews. 2008;40(2):187-224. PubMed PMID: 18464043. PubMed Central PMCID: 2752627.
Nischal PM. First global report on antimicrobial resistance released by the WHO. Natl Med J India. 2014 Jul-Aug;27(4):241-. PubMed PMID: WOS:000350087400016. English.
Riley MA, Robinson SM, Roy CM, Dennis M, Liu V, Dorit RL. Resistance is futile: the bacteriocin model for addressing the antibiotic resistance challenge. Biochem Soc T. 2012 Dec; 40:1438-42. PubMed PMID: WOS:000312096800048. English.
Santos, A. C. M.; Akkari, A. C. S.; Ferreira I. R. S., “Poloxamer-based binary hydrogels for delivering tramadol hydrochloride: sol-gel transition studies, dissolution-release kinetics, in vitro toxicity, and pharmacological evaluation,” International Journal of Nanomedicine, vol. 10, pp. 2391–2401, 2015.
Stein GE. The 4-quinolone antibiotics: past, present, and future. Pharmacotherapy. 1988;8(6):301-14. PubMed PMID: 2851772.
How to Cite
Copyright (c) 2022 Danilo Antonini Alves; João Paulo de Oliveira Guarnieri; Bruno Gaia Bernardes; Carlos Fernando Macedo da Silva; Marcelo Lancellotti
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.